| 1 |
Biib019 (daclizumab high yield process) |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
| 2 |
Biib019 (daclizumab) |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
| 3 |
Dac |
- |
- |
- |
- |
013 [3] 13, 90, 301 💬 |
| 4 |
Dac hyp |
- |
- |
- |
- |
013 [1] 13 💬 |
| 5 |
Dac-hyp |
- |
- |
- |
- |
013 [1] 13 💬 |
| 6 |
Dacepton 5 mg/ml |
- |
- |
- |
- |
006 [1] 6 💬 |
| 7 |
Dacepton 5 mg/ml infuusioneste, liuos |
- |
- |
- |
- |
006 [1] 6 💬 |
| 8 |
Daclizumab |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [7] 13, 56, 60, 65, 97, 283, 284 💬 |
| 9 |
Daclizumab (anti-cd25 humanized monoclonal antibody) |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
| 10 |
Daclizumab high yield process |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
| 11 |
Daclizumab hyp |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
| 12 |
Daclizumab hyp (dac hyp |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
| 13 |
Daclizumab hyp (dac hyp) |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
| 14 |
Daclizumab wih greek suffix |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
| 15 |
Daclizumab with greek suufix |
Daclizumab |
[1] D03639 D03639 💬 |
IL2RA [1] IL2RA 💬 |
Cytokine-cytokine receptor interaction [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 [1] 13 💬 |
| 16 |
Dacortin |
- |
- |
- |
- |
097 [1] 97 💬 |
| 17 |
Dacortin ® |
- |
- |
- |
- |
046 [1] 46 💬 |
| 18 |
Dacortín 2,5mg |
- |
- |
- |
- |
222 [1] 222 💬 |
| 19 |
Dacortín 30mg |
- |
- |
- |
- |
222 [1] 222 💬 |
| 20 |
Dacortín 5mg |
- |
- |
- |
- |
222 [1] 222 💬 |
| 21 |
Decitabine |
Decitabine |
[1] D03665 D03665 💬 |
DNMT1 [3] DNMT1, DNMT3A, DNMT3B 💬 |
Cysteine and methionine metabolism [3] Cysteine and methionine metabolism, Metabolic pathways, MicroRNAs in cancer |
063 [1] 63 💬 |
| 22 |
Device: medmont darl adapted chromatic (dac) |
- |
- |
- |
- |
090 [2] 90, 301 💬 |